DK3237433T3 - Fremgangsmåde til fremstilling af protein - Google Patents

Fremgangsmåde til fremstilling af protein

Info

Publication number
DK3237433T3
DK3237433T3 DK15813438.7T DK15813438T DK3237433T3 DK 3237433 T3 DK3237433 T3 DK 3237433T3 DK 15813438 T DK15813438 T DK 15813438T DK 3237433 T3 DK3237433 T3 DK 3237433T3
Authority
DK
Denmark
Prior art keywords
producing protein
protein
producing
Prior art date
Application number
DK15813438.7T
Other languages
English (en)
Inventor
Christopher Mark Illidge
Neil Alan Watson
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Application granted granted Critical
Publication of DK3237433T3 publication Critical patent/DK3237433T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK15813438.7T 2014-12-22 2015-12-18 Fremgangsmåde til fremstilling af protein DK3237433T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14199722 2014-12-22
PCT/EP2015/080526 WO2016102378A1 (en) 2014-12-22 2015-12-18 Method of protein manufacture

Publications (1)

Publication Number Publication Date
DK3237433T3 true DK3237433T3 (da) 2025-10-20

Family

ID=52282495

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15813438.7T DK3237433T3 (da) 2014-12-22 2015-12-18 Fremgangsmåde til fremstilling af protein

Country Status (24)

Country Link
US (1) US10626143B2 (da)
EP (1) EP3237433B1 (da)
JP (1) JP6807326B2 (da)
KR (1) KR102537099B1 (da)
CN (1) CN107108691B (da)
AU (1) AU2015371341B2 (da)
BR (1) BR112017013398B1 (da)
CA (1) CA2969981C (da)
CL (1) CL2017001633A1 (da)
CO (1) CO2017006157A2 (da)
DK (1) DK3237433T3 (da)
EA (1) EA039002B1 (da)
ES (1) ES3046837T3 (da)
FI (1) FI3237433T3 (da)
HR (1) HRP20251240T1 (da)
IL (1) IL252712B2 (da)
LT (1) LT3237433T (da)
MX (1) MX381459B (da)
MY (1) MY184085A (da)
PL (1) PL3237433T3 (da)
PT (1) PT3237433T (da)
SG (1) SG11201704841UA (da)
SI (1) SI3237433T1 (da)
WO (1) WO2016102378A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6807327B2 (ja) 2014-12-22 2021-01-06 ユーシービー バイオファルマ エスアールエル タンパク質製造
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
CN110386978A (zh) * 2018-04-19 2019-10-29 上海多米瑞生物技术有限公司 大肠杆菌周质空间表达的蛋白的提取方法
CN111965356B (zh) * 2019-11-28 2023-09-08 上海荣盛生物药业股份有限公司 巯基还原组合物及荧光微球层析试纸和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5655866A (en) 1995-03-20 1997-08-12 Bellanca; Joseph V. Method of folding a signature for use in bookbinding
AU3305100A (en) * 1999-03-17 2000-10-04 Medical Research Council Method for refolding molecules of polypeptides containing ig domains
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU2005310305A1 (en) * 2004-10-22 2006-06-08 Amgen Inc. Methods for refolding polypeptides
EP1805320B1 (en) * 2004-10-22 2014-09-03 Amgen Inc. Methods for refolding of recombinant antibodies
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0513852D0 (en) 2005-07-06 2005-08-10 Celltech R&D Ltd Biological products
CN101506222B (zh) 2006-07-14 2013-10-02 健泰科生物技术公司 重组蛋白的重折叠
US8617531B2 (en) * 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
BR112012022518A2 (pt) 2010-03-17 2020-10-13 Biogenerix Gmbh método para obtenção de g- csf recombinante humano biologicamente ativo
GB201012603D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
CA2815342A1 (en) 2010-10-20 2012-04-26 Medimmune, Llc Methods for processing inclusion bodies
JP6807327B2 (ja) 2014-12-22 2021-01-06 ユーシービー バイオファルマ エスアールエル タンパク質製造
GB201506870D0 (en) 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method

Also Published As

Publication number Publication date
AU2015371341A1 (en) 2017-06-29
CL2017001633A1 (es) 2017-11-24
MX381459B (es) 2025-03-12
JP2018505210A (ja) 2018-02-22
US20170342105A1 (en) 2017-11-30
HRP20251240T1 (hr) 2025-12-05
EA201791423A1 (ru) 2017-10-31
AU2015371341B2 (en) 2021-05-20
SI3237433T1 (sl) 2025-11-28
IL252712B1 (en) 2023-12-01
CA2969981C (en) 2024-06-25
JP6807326B2 (ja) 2021-01-06
CN107108691A (zh) 2017-08-29
IL252712B2 (en) 2024-04-01
EP3237433B1 (en) 2025-07-30
LT3237433T (lt) 2025-11-10
IL252712A0 (en) 2017-08-31
ES3046837T3 (en) 2025-12-02
PT3237433T (pt) 2025-10-21
KR20170090510A (ko) 2017-08-07
SG11201704841UA (en) 2017-07-28
EA039002B1 (ru) 2021-11-19
CN107108691B (zh) 2021-06-29
BR112017013398B1 (pt) 2023-12-05
WO2016102378A1 (en) 2016-06-30
PL3237433T3 (pl) 2025-12-08
BR112017013398A2 (pt) 2018-03-06
CA2969981A1 (en) 2016-06-30
CO2017006157A2 (es) 2017-09-20
MY184085A (en) 2021-03-17
KR102537099B1 (ko) 2023-05-25
US10626143B2 (en) 2020-04-21
FI3237433T3 (fi) 2025-10-14
MX2017007670A (es) 2017-10-27
EP3237433A1 (en) 2017-11-01

Similar Documents

Publication Publication Date Title
IL261271A (en) Methods for making l-glufosinate
IL251963A0 (en) Anti-pd-1 antibodies
IL249981A0 (en) Method
DK3160994T3 (da) Multispecifikke antigenbindende proteiner
DK3126395T3 (da) Multispecifikke antistoffer
DK3183272T3 (da) Asymmetriske multispecifikke antistoffer
EP3182987C0 (en) HUMANIZED ANTI-TAU ANTIBODIES
DK3122444T3 (da) Fremgangsmåde til fremstilling af membraner
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
FI20146127A7 (fi) Prosessi hiilivetyjen valmistamiseksi
DK3157559T3 (da) Anti-axl-antistoffer
DK3125898T3 (da) Farmakofor til trail-induktion
DK3341479T3 (da) LNA-G-Proces
DK2966044T3 (da) Fremgangsmåde til fremstilling af skumglas
DK3237432T3 (da) Proteinfremstilling
DK3166904T3 (da) Fremgangsmåde til fremstilling af betonelementer
HUE057118T2 (hu) Folyamat
DK3147369T3 (da) Fremgangsmåde til produktion af fibroinlignende protein
HUE049170T2 (hu) Eljárás szubsztituált cikloszerinek elõállítására
EP3160502B1 (en) BI-SPECIFIC ANTIBODIES ANTI-IL4-IL13
DK3166923T3 (da) Fremgangsmåde til fremstilling af substituerede phenylalkaner
HUE054148T2 (hu) Anti-ORAI1 antitest
EP3523659C0 (en) MULTI-PROTEASE PROCESS
DK3174402T3 (da) Fremgangsmåde til fremstilling af mælkepulver
DK3131567T3 (da) Fremgangsmåde til fremstilling af GNRH-holdig gel